Overview

A Trial Evaluating the Efficacy and Safety of HSK3486 Injectable Emulsion for the Induction of General Anesthesia in Elective Surgery Subjects

Status:
Completed

Trial end date:
2019-09-03

Target enrollment:

Participant gender:

Summary

This is a multi-center, randomized, double-blind, propofol-controlled phase III clinical trial. The primary objective is to compare the efficacy and safety between propofol and HSK3486 for the induction of general anesthesia in elective surgery subjects, so as to provide reference for marketing registration of HSK3486.

Phase:

Phase 3

Details

Lead Sponsor:

Sichuan Haisco Pharmaceutical Group Co., Ltd
Sichuan Haisco Pharmaceutical Group Co., Ltd.

Treatments:

Propofol